Optimizing In Situ Vaccination During Radiotherapy

Effective in situ cancer vaccines require both a means of tumor cell death and a source of adjuvant to activate local dendritic cells. Studies have shown that the use of radiotherapy (RT) to induce tumor cell death and anti-CD40 to activate dendritic cells can result in in situ vaccination in animal...

Descripción completa

Detalles Bibliográficos
Autores principales: Yasmin-Karim, Sayeda, Wood, Jana, Wirtz, Johanna, Moreau, Michele, Bih, Noella, Swanson, William, Muflam, Ashley, Ainsworth, Victoria, Ziberi, Bashkim, Ngwa, Wilfred
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8577814/
https://www.ncbi.nlm.nih.gov/pubmed/34765538
http://dx.doi.org/10.3389/fonc.2021.711078

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8577814/
https://www.ncbi.nlm.nih.gov/pubmed/34765538
http://dx.doi.org/10.3389/fonc.2021.711078

Ejemplares similares